Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

p21cip1 is required for the differentiation of oligodendrocytes independently of cell cycle withdrawal.

Zezula J, Casaccia-Bonnefil P, Ezhevsky SA, Osterhout DJ, Levine JM, Dowdy SF, Chao MV, Koff A.

EMBO Rep. 2001 Jan;2(1):27-34.

2.

Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase.

Hsieh FF, Barnett LA, Green WF, Freedman K, Matushansky I, Skoultchi AI, Kelley LL.

Blood. 2000 Oct 15;96(8):2746-54.

3.

Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines.

Koga H, Sakisaka S, Harada M, Takagi T, Hanada S, Taniguchi E, Kawaguchi T, Sasatomi K, Kimura R, Hashimoto O, Ueno T, Yano H, Kojiro M, Sata M.

Hepatology. 2001 May;33(5):1087-97.

PMID:
11343236
4.

Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta.

Reynisdóttir I, Polyak K, Iavarone A, Massagué J.

Genes Dev. 1995 Aug 1;9(15):1831-45.

5.

Regulation of cyclin dependent kinase inhibitor proteins during neonatal cerebella development.

Watanabe G, Pena P, Shambaugh GE 3rd, Haines GK 3rd, Pestell RG.

Brain Res Dev Brain Res. 1998 Jun 15;108(1-2):77-87.

PMID:
9693786
6.
7.

RANKL coordinates cell cycle withdrawal and differentiation in osteoclasts through the cyclin-dependent kinase inhibitors p27KIP1 and p21CIP1.

Sankar U, Patel K, Rosol TJ, Ostrowski MC.

J Bone Miner Res. 2004 Aug;19(8):1339-48. Epub 2004 Mar 29.

8.

Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.

Sangfelt O, Erickson S, Castro J, Heiden T, Gustafsson A, Einhorn S, Grandér D.

Oncogene. 1999 May 6;18(18):2798-810.

9.

The cyclin-dependent kinase inhibitors p27Kip1 and p21Cip1 cooperate to restrict proliferative life span in differentiating ovarian cells.

Jirawatnotai S, Moons DS, Stocco CO, Franks R, Hales DB, Gibori G, Kiyokawa H.

J Biol Chem. 2003 May 9;278(19):17021-7. Epub 2003 Feb 27.

10.

Involvement of p21(WAF1/Cip1) and p27(Kip1) in intestinal epithelial cell differentiation.

Tian JQ, Quaroni A.

Am J Physiol. 1999 Jun;276(6 Pt 1):C1245-58.

11.

Differential effects of the cyclin-dependent kinase inhibitors p27(Kip1), p21(Cip1), and p16(Ink4) on vascular smooth muscle cell proliferation.

Tanner FC, Boehm M, Akyürek LM, San H, Yang ZY, Tashiro J, Nabel GJ, Nabel EG.

Circulation. 2000 May 2;101(17):2022-5.

12.

Involvement of p21 and p27 in the regulation of CDK activity and cell cycle progression in the regenerating liver.

Albrecht JH, Poon RY, Ahonen CL, Rieland BM, Deng C, Crary GS.

Oncogene. 1998 Apr 23;16(16):2141-50.

13.
14.
15.

Neurotransmitter receptor activation triggers p27(Kip1 )and p21(CIP1) accumulation and G1 cell cycle arrest in oligodendrocyte progenitors.

Ghiani CA, Eisen AM, Yuan X, DePinho RA, McBain CJ, Gallo V.

Development. 1999 Feb;126(5):1077-90.

16.

Biphasic regulation of breast cancer cell growth by progesterone: role of the cyclin-dependent kinase inhibitors, p21 and p27(Kip1).

Groshong SD, Owen GI, Grimison B, Schauer IE, Todd MC, Langan TA, Sclafani RA, Lange CA, Horwitz KB.

Mol Endocrinol. 1997 Oct;11(11):1593-607.

PMID:
9328342
18.

Thrombopoietin-induced differentiation of a human megakaryoblastic leukemia cell line, CMK, involves transcriptional activation of p21(WAF1/Cip1) by STAT5.

Matsumura I, Ishikawa J, Nakajima K, Oritani K, Tomiyama Y, Miyagawa J, Kato T, Miyazaki H, Matsuzawa Y, Kanakura Y.

Mol Cell Biol. 1997 May;17(5):2933-43.

19.

Hepatitis B virus X protein increases expression of p21(Cip-1/WAF1/MDA6) and p27(Kip-1) in primary mouse hepatocytes, leading to reduced cell cycle progression.

Qiao L, Leach K, McKinstry R, Gilfor D, Yacoub A, Park JS, Grant S, Hylemon PB, Fisher PB, Dent P.

Hepatology. 2001 Nov;34(5):906-17.

PMID:
11679961
20.

Supplemental Content

Support Center